← Open Payments lookup

SAMUEL MINGLE: Open Payments

NPI 1275067183 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$848 in 22 payments from 10 companies in 2025. Trend: 2023 $130 · 2024 $155 · 2025 $848

Food & beverage: $757Education: $91
CompanyPaymentsAmount
Penumbra, Inc.1$172
Neurocrine BioSciences, Inc.2$162
Teva Pharmaceuticals USA, Inc.4$140
Takeda Pharmaceuticals U.S.A., Inc.4$104
Alkermes, Inc.2$52
E.R. Squibb & Sons, L.L.C.2$48
Collegium Pharmaceutical, Inc.2$46
Vanda Pharmaceuticals Inc.2$44
Axsome Therapeutics, Inc.2$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$36

Products named: RUBY Coil, INGREZZA, TRINTELLIX, ARISTADA, UZEDY, COBENFY, Jornay PM, FANAPT.

Industry payments across CO — which companies pay providers there.